Upstream Bio Sets Phase 3 Plans for Verekitug in Asthma
WALTHAM, Mass., Sept. 1, 2026 Upstream Bio, Inc. has announced its pivotal Phase 3 development plans for verekitug in...
Chronic Rhinosinusitis
Advertisement
Airiver Treats First Patient in Pivotal CRS Balloon Trial
BROOKLYN PARK, Minn., June 11, 2026 Airiver Medical has announced the successful treatment of the first patient in its...
Kashiv BioSciences Moves Closer to Launching XOLAIR Biosimilar in Canada
PISCATAWAY, N.J., June 4, 2026 Kashiv BioSciences has announced a significant regulatory milestone with the validation and acceptance by...
FDA Approves TEZSPIRE for Chronic Rhinosinusitis with Nasal Polyps
THOUSAND OAKS, Calif., October 17, 2025 — In a landmark regulatory decision, the U.S. Food and Drug Administration (FDA)...
Advertisement
